The influence of antioxidant supplementation on adverse effects and tumor interaction during radiotherapy: a systematic review
Open Access
- 22 July 2025
- journal article
- review article
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 25 (1) , 1-26
Abstract
Radiotherapy is essential in cancer treatment, using ionizing radiation to generate free radicals in the irradiated tissue or to directly damage DNA. Despite comprehensive safety measures, healthy tissue is also irradiated, causing side effects like oral mucositis and dermatitis. Antioxidants, which are known for scavenging free radicals, may reduce these adverse effects, but their impact on radiotherapy efficacy remains unclear. The aim of this systematic review was to evaluate the influence of antioxidant supplementation on radiation-induced side effects, tumor outcome and quality of life. In April 2024, a systematic research was conducted searching five databases (Medline, CINAHL, EMBASE, Cochrane CENTRAL, PsycINFO) to find studies looking at the effect of antioxidant supplementation during radiotherapy on radiation-induced side effects and parameters of tumor outcome or survival. Antioxidants can mitigate radiation-induced side effects, with vitamins C and E showing positive effects on oral mucositis, xerostomia and cardiac function. Curcumin and EGCG improved symptoms such as mucositis, dermatitis and esophagitis, while glutathione-enhanced treatment compliance but did not provide significant protection against side effects. However, multiple studies indicate that the concurrent use of antioxidants during cancer treatment may impair tumor control, increase recurrence rates and reduce survival outcomes. Antioxidants may reduce radiation-induced side effects but could compromise treatment efficacy. Due to inconsistent evidence and potential risks, clinical recommendations are premature. Further high-quality research is needed.Keywords
Funding Information
- Universitätsklinikum Jena
This publication has 68 references indexed in Scilit:
- Efficacy of Epigallocatechin-3-Gallate in Preventing Dermatitis in Patients With Breast Cancer Receiving Postoperative RadiotherapyJAMA Dermatology, 2022
- Pentoxifylline and vitamin E reduce the severity of radiotherapy-induced oral mucositis and dysphagia in head and neck cancer patients: a randomized, controlled studyMedical Oncology, 2019
- Randomized, double‐blind, placebo‐controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapyPhytotherapy Research, 2018
- Vitamin C protects against ionizing radiation damage to goblet cells of the ileum in ratsActa Histochemica, 2008
- Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long‐term effects on recurrence and mortality: A randomized trial among head and neck cancer patientsInternational Journal of Cancer, 2008
- Pentoxifylline and alpha-tocopherol in prevention of radiation-induced lung toxicity in patients with lung cancerMedical Oncology, 2007
- Antioxidant vitamins supplementation and mortality: A randomized trial in head and neck cancer patientsInternational Journal of Cancer, 2006
- A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Retinol Palmitate (Vitamin A) for Symptomatic Chronic Radiation ProctopathyDiseases of the Colon & Rectum, 2005
- Protective effect of alpha‐tocopherol in head and neck cancer radiation‐induced mucositis: A double‐blind randomized trialHead & Neck, 2004
- A double-blind, randomized, prospective trial to evaluate topical vitamin C solution for the prevention of radiation dermatitisInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1993